Sonidegib

BreastfeedingPediatric

FDA APPROVAL DATE: 07/24/2015

CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Atazanavir, Carbamazepine, Diltiazem, Efavirenz, Fluconazole, Itraconazole, Ketoconazole, Modafinil, Nefazodone, Phenobarbital, Phenytoin, Posaconazole, Rifabutin, Rifampin, Saquinavir, St John's Wort, Telithromycin, Voriconazole

PREGNANCY CATEGORY: N/A
Can cause fetal harm

Patients should not donate blood or blood products while receiving sonidegib and for at least 20 months after the last dose.

EMBRYO-FETAL TOXICITY

See full prescribing information for complete boxed warning.

Our database has 29 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
ENDOCRINE/METABOLIC
HEMATOLOGIC
OTHER


Page last updated 05/04/2017

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric